[ad_1]
HAVANA.- Recording in nearly 30 countries from all latitudes and a group of 290,000 patients treated since its release a decade ago is one of the achievements of Heberprot-P, the only drug in the world to be treated diabetic foot ulcers .
In fact, the disease, considered a global pandemic, has a high incidence on the island, with numbers approaching one million inhabitants.
The research badociated with this drug and the pharmacovigilance studies do not stop. Its developers, Center for Genetic Engineering and Biotechnology (CIGB), are now looking for the injectable, whose active ingredient is the epidermal growth factor, to be less invasive for the patient.
Administered directly into ulcerated tissues, she infiltrated with the help of a needle into the lesions, up to a depth of 0.1 cm.
Such a procedure sometimes causes pain in the patient, especially at the edges and funds of lesions at the time of application, explained this intervention. The Cuban journalist Jorge Berlanga, responsible for the study
The group of formulations of the CIGB works in search of a new pharmaceutical form, so-called intelligent formulations, characterized by a sustained release pattern over time . 19659002] The goal is to reduce the number of treatments, with this hypothesis is worked out.
"In this way, if some of the alternatives are realized, it would be a step forward, but also a big challenge.It should be seen how the cell reacts to the presence of a sustained release, as and as the recipient changes, it's a challenge ahead, "says Berlanga.
patients a unique medicine in the world to treat this medical problem is not the solution. Scientists argue that prevention work is needed, especially in a country whose forecasts indicate that one-third of the population, adults over 60 years old account for one-third of the population.
In addition to being a social problem, since the economic point of view is necessary to control the evolution of the disease since primary care, because, in the opinion of specialists, many injuries come to be treated and closed at the beginning, when the complexity is low.
In this way, costs are reduced. direct and indirect health systems. This contributes to the family economy and that of the country, they explain.
At the same time, the Angolan Cuban community has been focusing for several years on applying better epidemiological strategies to at least cope with possible diseases that approach us. Alejandro Hernández, director of the Institute of Angiology and Vascular Surgery, about AngioCaribe 2016.
The development of prevention programs at the primary care level, so as not to reach the difficult situations in patients, is one of the
At that time, the entity presented the study Magnitude and transcendence of peripheral vascular disease in Cuba to uncover the prevalence of these diseases on the island .
It was deduced from their results that peripheral vascular diseases appeared in of Cuba among the top 10 causes of death (seventh place), with a gross mortality of 25.5 per 100,000 inhabitants hence the need for coherent intervention strategies, because, as statistics show, in the world, in the case of peripheral arterial diseases, two-thirds of people are asymptomatic and under-diagnosed.
In the light of these circumstances, the above-mentioned scientific institutions are organizing the international congress entitled Control of Diabetes and its Most Serious Complications, a meeting bringing together researchers from all latitudes and a broad representation of the United States. [19659002] In fact, the American nation wants this drug. Earlier this year, CIGB's Heber Biotec of Cuba and Mercurio Biotec of the United States decided to join forces to have Heberprot-P treatment given to patients suffering from diabetic foot ulcers in the northern hemisphere. . Food from this country (the FDA).
Scientists from the United States and colleagues from other parts of the world will be able to learn about the latest advances in the treatment of this disease at five symposia, including them. Endocrinology of diabetes, state of the art in the treatment of wound healing, as well as implementation of health programs for the comprehensive care of people with diabetes.
These problems add to the cardiovascular problems badociated with diabetes and their implementation. health programs for the full care of people with diabetes.
Source link
